CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.

Media Contact: [email protected]

U.S. House Passes R&D Tax Fix

Feb 7, 2024

On January 31, the U.S. House of Representatives passed the Tax Relief for American Families and Workers Act by a broad, bipartisan vote of 357-70. A critical part of this..

Read More

CLS Comments on NIST Draft March-In Rights Framework

Feb 7, 2024

CLS submitted comments to the National Institute of Standards and Technology’s Request for Information on the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights. In our response,..

Read More

California Life Sciences CEO Mike Guerra joins life sciences leaders to celebrate investment in biotech at New York Stock Exchange

Jan 3, 2024

January 3, 2024, New York, NY – California Life Sciences (CLS) joined fellow trade organizations from across the country to ring the closing bell at the New York Stock Exchange..

Read More

Overriding patent rights will harm California’s life sciences innovation

Dec 8, 2023

December 8, 2023 California Life Sciences President & CEO Mike Guerra releases statement on Biden Administration’s Proposed Framework on March-in rights: “California Life Sciences is discouraged by the Biden administration’s..

Read More